血管內(nèi)皮生長因子C(VEGFC)單克隆抗體
Monoclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
VEGF-C; Flt4-L; VRPL; Vascular Endothelial Growth Factor-Related Protein
- 編號MAA145Hu21
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)E2
- Ig亞型 IgG1 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原 RPA145Hu01-血管內(nèi)皮生長因子C(VEGFC)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度1mg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù),請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 540 ¥ 1260 ¥ 1800 ¥ 4500 ¥ 18000
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對VEGFC的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別VEGFC。
用法
Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APA145Hu61 | 血管內(nèi)皮生長因子C(VEGFC)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA145Hu01 | 血管內(nèi)皮生長因子C(VEGFC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA145Hu02 | 血管內(nèi)皮生長因子C(VEGFC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA145Hu62 | 血管內(nèi)皮生長因子C(VEGFC)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA145Hu63 | 血管內(nèi)皮生長因子C(VEGFC)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA145Hu61 | 血管內(nèi)皮生長因子C(VEGFC)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA145Hu01 | 血管內(nèi)皮生長因子C(VEGFC)活性蛋白 | Cell?culture;?Activity?Assays. |
PAA145Hu01 | 血管內(nèi)皮生長因子C(VEGFC)多克隆抗體 | WB; IHC; ICC; IP. |
MAA145Hu23 | 血管內(nèi)皮生長因子C(VEGFC)單克隆抗體 | WB; IHC; ICC; IP. |
MAA145Hu24 | 血管內(nèi)皮生長因子C(VEGFC)單克隆抗體 | WB; IHC; ICC; IP. |
MAA145Hu22 | 血管內(nèi)皮生長因子C(VEGFC)單克隆抗體 | WB; IHC; ICC; IP. |
MAA145Hu21 | 血管內(nèi)皮生長因子C(VEGFC)單克隆抗體 | WB; IHC; ICC; IP. |
MEA145Hu | 血管內(nèi)皮生長因子C(VEGFC)檢測試劑盒(酶聯(lián)免疫吸附試驗法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SEA145Hu | 血管內(nèi)皮生長因子C(VEGFC)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCA145Hu | 血管內(nèi)皮生長因子C(VEGFC)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMA145Hu | 血管內(nèi)皮生長因子C(VEGFC)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA145Hu01 | 血管內(nèi)皮生長因子C(VEGFC)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Journal of Cellular Biochemistry | Alternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma [PubMed: 19241443] |
genetics and molecular research | Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages [PubMed: 26125824] |
Experimental and Therapeutic | Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia [PubMed: 26622498] |
Am J Pathol | IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages [PubMed: 26608451] |
PLoS One. | Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells. [pubmed:27383632] |
Oncology?Letters | RNAi-mediated?gene?silencing?of?vascular?endothelial?growth?factor?C?suppresses?growth?andinduces?apoptosis?in?mouse?breast?cancer?in?vitro?and in?vivo. [pubmed:27895746] |
Angiogenesis | Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering [Pubmed:29582235] |
Oncology Reports | Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells [Pubmed:29328465] |
LABORATORY INVESTIGATION | Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease [Pubmed: 31019289] |
Cutaneous and Ocular Toxicology | Isotretinoin does not alter VEGF-A and VEGF-C levels: Do retinoids behave differently in dose-dependent and/or in vivo/in vitro conditions? [Pubmed: 32722957] |
留言咨詢